Repligen Corporation (RGEN)

NASDAQ
191.52
+1.52(+0.80%)
After Hours
191.01
-0.51(-0.27%)
- Real-time Data
  • Volume:
    248,623
  • Bid/Ask:
    170.00/192.99
  • Day's Range:
    189.60 - 192.97

RGEN Overview

Prev. Close
190
Day's Range
189.6-192.97
Revenue
433.01M
Open
191.37
52 wk Range
109.38-228.84
EPS
1.44
Volume
248,623
Market Cap
10.52B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
409,634
P/E Ratio
132.87
Beta
0.85
1-Year Change
63.93%
Shares Outstanding
54,904,466
Next Earnings Date
Aug 05, 2021
What is your sentiment on Repligen Corporation?
or
Market is currently closed. Voting is open during market hours.

Repligen Corporation News

Repligen Corporation Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Repligen Corporation Company Profile

Repligen Corporation Company Profile

Employees
1128

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.

Read More
  • RGEN is one of the best now. Screening and Evaluation https://onlythegoodyoung.hatenablog.com/entry/2021/03/14/100750
    0
    • Galoot manager made a "right" decision without thinking.
      0
      • Why the drop, cant find any news
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.